CLINICAL ROLE -
Vaccination Status of Patients with Hematologic Malignancies Not Correlated with Severity of COVID-19 Infection
Although vaccination status and the severity of COVID-19 infection were not correlated, the timing of vaccine administration influenced whether patients had severe COVID-19 infection.
FDA Approves First Therapy for Rare Invasive Tumor Type With High Risk of Recurrence
In a phase 3 trial, none of the patients receiving nirogacestat reached median progression-free survival, indicating that it may effectively reduce disease progression.
Antibodies That Can Prevent HIV-1 Infection Remain Detectable Even at Low Antigen Levels
The finding indicates that a potential vaccine can trigger a permanent response in individuals living with HIV-1.
Study: Food Insecurity Associated With Increased Risk of Dementia
Food insecurity was associated with an increased risk of dementia, poorer memory function, and faster memory decline in older adults.
Peanut Protein Therapy Provides Safe and Effective Treatment for Peanut-Allergic Children
Peanut sublingual immunotherapy offers a practical treatment option for peanut-allergic toddlers, reducing symptoms in 80% of children.
Doxycycline for Post-Exposure Prophylaxis of Sexually Transmitted Infections
In addition to growing rates of STIs, there is concern for antimicrobial resistance to STIs.
Empathy, Uncertainty Reductions Promote Psychological Well-Being in Patients with Breast Cancer
The investigators note that continued support during breast cancer treatment is necessary for patient comfort beyond diagnosis and the initial phases of treatment.
FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma
The update followed results from the phase 1/2 EPCORE NHL-1 clinical trial evaluating the safety and preliminary efficacy of the drug, including in individuals with relapsed or refractory follicular lymphoma.
Clinical Updates On COVID-19 Vaccine Options for Patients
Regardless of which of these vaccines patients receive, as long as they receive them according to the prescribed schedules, they can protect themselves and their community against the COVID-19 virus.
Independent Rx Forum: NCPA Priorities, Legislative Updates for Independent Pharmacies
Tune in to this episode of the Independent Rx Forum for a comprehensive overview of the National Community Pharmacists Association's legislative priorities, updates on critical pharmacy-related bills, and insights into the legislative process.
Study Indicates Potential of Pembrolizumab in Advanced Melanoma
A change in recurrence-free survival was also observed, with an 89% rate at 24 months in patients who achieved a complete pathologic response.
Study Results Demonstrate Early Potential of Breast Cancer Treatment With Minimal Adverse Effects
TcdBFBD, derived from a toxin found in Clostridium difficile, was tested in mouse models that mimicked different subtypes of breast cancer.
Pharmacist Spotlight: Joanna Lewis, PharmD, MBA
Fun Facts: Are Antacids Just Chalk?
Barriers to PrEP Access Continue to Grow Among Those Most at Risk of HIV
Although social determinants of health (SDOH) have been a major barrier to access of preexposure prophylaxis for those who are at risk of HIV, commercial determinants of health pose a similar barrier.
Progressions in HIV Research Compromised by COVID-19 Pandemic
Study results indicate that outcomes were worse among those who inject illicit drugs and Black patients living with HIV.
Prescription: Beyfortus From Sanofi Pasteur, Inc
Study: Cost of Permanent Pacemakers for Pediatric Patients Grows After Congenital Heart Surgery
Heart failure is a major cause of morbidity and mortality for adults with congenital heart disease (CHD), with the highest risk being for those with complex CHD lesions.
Pharmacists Can Increase Access to Care for Patients With ATTR-CM
Major barriers to care for patients with transthyretin amyloid cardiomyopathy (ATTR-CM) can include navigating therapeutics and the cost of medications.
Treatment Opportunities Continue to Advance in CLL Management
In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.
Prior Authorizations Pose Barrier to Access for HIV Preexposure Prophylaxis
The study authors reported that plans in the South had the highest rates of exclusive PAs for either emtricitabine/tenofovir disoproxil fumarate or emtricitabine/tenofovir alafenamide even if the plan covered both, from 2018 to 2020.
Patients’, Health Care Professionals’ Reporting of Comorbidities, Symptoms Varies in Breast Cancer
The study findings indicate that health care professionals significantly underreport symptoms compared to patients with breast cancer, with reported comorbidities varying.
There Are Increasing Opportunities for Community Pharmacies to Help Patients With Anemia in Condition Management
Pharmacies have the potential to introduce testing services, promote public health campaigns, collaborate with anemia-led clinics, and get more prescribing rights to diagnose anemia.
Addressing Burnout: When the Body Says ‘Enough’
In part 2 of this series, trauma-informed pharmacist Helen Sairany, PharmD, MBA, discusses the physical manifestations of burnout.
Holiday Gift Ideas for Pharmacists and Pharmacy Technicians
For pharmacists and pharmacy technicians, who work diligently to ensure our health and well-being, choosing the perfect holiday gift can be a thoughtful way to express gratitude and brighten their season.
Children Remain High Risk for Antiphospholipid Syndrome
Pediatric individuals that are higher risk for APS must be followed to better understand affects
FDA to Review sBLA For Idecabtagene Vicleucel in the Early Treatment of Adult Patients with RRMM
The review comes after phase 3 trial results that indicate an improvement in overall survival and progression-free survival, reducing the risk of disease progression and death.
FDA Issues Fast Track Designation to ADP101 for Mono-, Multi-Food Allergies
The designation allows expedited development of ADP101 as a treatment for food allergy in children ages 4 to 17 with confirmed allergy to 1 or more of the 15 foods in the drug product.
Study: Pneumococcal Vaccines Do Not Prevent Development of Otitis Media in Infants
According to the investigators, Streptococcus pneumoniae and non-typeable Haemophilus influenzae are dominant pathogens of otitis media after birth.
Researchers Create Growth Chart from AI-Based Tool to Measure Muscle Mass
The growth chart could be a fast and accessible resource to indicate lean muscle mass in children.
2 Clarke Drive Cranbury, NJ 08512